Activity | Treatment | |||||
---|---|---|---|---|---|---|
None | BZN | Mix 3 | Mix 4 | Mix 10 | Mix 12 | |
Uninfected J774A.1 macrophages | ||||||
CC50 (μg/mL) | – | 298 | – | – | – | – |
FICa | – | – | – | 1.7 | 0.9 | 1 |
O2− Mitochondrialc | 0.53 | 0.97 | 1.8 | – | 0.91 | – |
ΔΨmb | N | N | 0.85 | N | N | N |
Genome DNAd | N | F | N | N | N | N |
Cellular membranee | N | N | N | N | N | N |
Death phenotypeg | ND | ND | ND | ND | ND | ND |
IFN-γ (10−8 pg/mL)h | – | 1.4 | 0 | 2.2 | 2.3 | 1.4 |
IL-2 (10−4 pg/mL) h | – | 1.5 | 3.2 | 2.6 | 2.4 | 1.5 |
TNF-α (pg/mL) h | – | 70.3 | 3.4 | 2.8 | 14.7 | 1.8 |
RANTES (pg/mL) h | – | 30.3 | 2.5 | 2.9 | 4.8 | 1.7 |
IL-10 (10−3 pg/mL) h | – | 0.8 | 1.9 | 0.6 | 0.4 | 2.5 |
IL-4 (10−6 pg/mL) h | – | 2.4 | 1.5 | 7.3 | 4.9 | 2.5 |
Genotoxicityf | – | |||||
% Type 0 | 100 | – | 57 | 41 | 6 | |
% Type 1 | – | 1 | 36 | 41 | 54 | 90 |
% Type 2 | – | 7 | 53 | 2 | 4 | 4 |
% Type 3 | – | 89 | 8 | 0 | 1 | 0 |
% Type 4 | – | 3 | 3 | 0 | 0 | 0 |
T. cruzi-Infected J774A.1 macrophages | ||||||
IC50 (μg/mL) | – | 48 | – | – | – | 1 |
FICa | – | – | 0.4 | 0.6 | 0.4 | – |
O2− Mitochondrialc | 0.98 | 1.56 | 0.77 | – | 0.82 | – |
ΔΨmb | ↓ | ↓ | ↓↓↓ | – | ↓↓↓ | – |
Genome DNAd | N | F | F | – | F | – |
Cellular membranee | N | D | N | – | N | – |
Death phenotypeg % Type of Death | N | Nec 60 | Apop 80 | – | Apop 80 | 0 |
IFN-γ (10−8 pg/mL) h | 4.0 | 3.5 | 2.2 | 0.8 | 0.4 | 0 |
IL-2 (10−4 pg/mL) h | 4.4 | 3.9 | 2.5 | 0.9 | 0.5 | 8.4 |
TNF-α (pg/mL) h | 24.6 | 81.2 | 3.9 | 12.6 | 73.3 | 7.1 |
RANTES (pg/mL) h | 29.3 | 50.1 | 4.8 | 6.5 | 23.0 | 0.5 |
IL-10 (10−3 pg/mL) h | 0.5 | 1.3 | 0.6 | 0.4 | 0.8 | 7.3 |
IL-4 (10−6 pg/mL) h | 2.4 | 0 | 2.5 | 7.4 | 2.5 | 8 |